Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
short-term repeated dose toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
1976.
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1977
Report date:
1976

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
Deviations:
yes
Remarks:
only one dose tested, analytical verification of doses not reported.
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Diosmin
EC Number:
208-289-7
EC Name:
Diosmin
Cas Number:
520-27-4
Molecular formula:
C28H32O15
IUPAC Name:
diosmin
Test material form:
not specified

Test animals

Species:
rat
Strain:
other: GIF
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Initial weight: 200-280g

Administration / exposure

Route of administration:
oral: feed
Vehicle:
unchanged (no vehicle)
Analytical verification of doses or concentrations:
not specified
Details on analytical verification of doses or concentrations:
No data.
Duration of treatment / exposure:
50 days
Frequency of treatment:
daily
Doses / concentrations
Dose / conc.:
200 mg/kg bw/day (nominal)
No. of animals per sex per dose:
10 animals (m/f).
Control animals:
yes, concurrent no treatment

Examinations

Observations and examinations performed and frequency:
CAGE SIDE OBSERVATIONS: Not specified
DETAILED CLINICAL OBSERVATIONS: Not specified

BODY WEIGHT: Yes
- Time schedule for examinations: weekly.

FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): weekly controls.
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Not specified

FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: Not specified

OPHTHALMOSCOPIC EXAMINATION: No

HAEMATOLOGY: Yes (blood counts)
- Time schedule for collection of blood: at 0, 25 and 50 days of treatment.
- Anaesthetic used for blood collection: Not specified
- Animals fasted: Not specified
- How many animals: 10.

CLINICAL CHEMISTRY: Yes
- How many animals: 10.
- Parameters examined: haemoglobin, urea , GPT and GOT

URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: Not specified
IMMUNOLOGY: No
Sacrifice and pathology:
GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes
- Macroscopical and microscopical examinations of spleen, kidney, heart, liver, lung and bladder were performed on all animals.

Results and discussion

Results of examinations

Clinical signs:
no effects observed
Mortality:
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Food efficiency:
no effects observed
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
no effects observed
Clinical biochemistry findings:
no effects observed
Urinalysis findings:
not examined
Behaviour (functional findings):
no effects observed
Immunological findings:
not examined
Organ weight findings including organ / body weight ratios:
not examined
Gross pathological findings:
no effects observed
Neuropathological findings:
not examined
Histopathological findings: non-neoplastic:
no effects observed
Histopathological findings: neoplastic:
no effects observed
Other effects:
no effects observed
Details on results:
Treatment of white rats with diosmin in a dosage of 200 mg/kg daily in diet for 50 days led to no toxic manifestations.

Effect levels

Key result
Dose descriptor:
NOAEL
Effect level:
>= 200 mg/kg bw (total dose)
Based on:
test mat.
Sex:
male/female
Remarks on result:
not determinable due to absence of adverse toxic effects

Target system / organ toxicity

Key result
Critical effects observed:
no

Applicant's summary and conclusion

Conclusions:
Under test conditions the test item was found to be non toxic, with a NOAEL ≥ 200 mg/kg bw.
Executive summary:

A study on the subacute oral toxicity of the test item in rats was performed with a procedure similar to OECD 407 (no GLP). White GIF-strain rats received the test item at a dose of 200 mg/kg bw test item in their diet per day for 50 days, and the following parameters were examined: weight development, blood count, macroscopic and histologic assessment of organs, and biochemistry (GOT, GPT, urea). Under test conditions, the test substance showed no toxic effects. Therefore, the NOAEL of the test item in rats is ≥ 200 mg/kg bw.